Dose-Dense and Sequential Strategies in Adjuvant Breast Cancer Therapy
ByMichael Untch, MD, PhD,Franz Von Koch, MD,C. Crohns, MD,K. Sobotta, MD,Steffen Kahlert, MD,Gottfried E. Konecny, MD,H. Hepp, MD
Published: | Updated:
Several attempts have been made to improve the survival rates of breast cancer patients. The benefit of adjuvant chemotherapy was clearly shown, but the absolute difference of 2% to 11% in overall survival, depending on the